SSX Polyclonal Antibody

活动价:

¥680.00

市场价:¥880.00

一键复制产品信息
产品规格:
  • 50μL
  • 100μL
货号:

FAB2617017

  • 产品信息
  • 注意事项
  • 实验验证
  • 产品声明
  • 引用文献
  • 相关产品
  • 文件下载
商品描述
  • 靶点-Target

    SSX

  • 反应性

    Human

  • 应用

    WB,IHC,IF,ELISA

  • 宿主物种-Host Species

    Rabbit

  • 同种型-Isotype

    IgG

  • 修饰-Modification

    Unmodified

  • MW(Observed)

    25kD

  • 推荐稀释比

    WB 1:500-1:2000;IHC: 1:100-300;ELISA 1:20000;IF 1:50-200

  • 组成

    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

  • 纯化工艺

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

  • 储存

    -15°C to -25°C/1 year(Do not lower than -25°C)

  • 浓度

    1 mg/ml

  • 克隆性

    Polyclonal

  • 免疫原

    The antiserum was produced against synthesized peptide derived from the C-terminal region of human SSX1/2/3/4/5/6/7/8/9. AA range:139-188

  • 特异性

    SSX Polyclonal Antibody detects endogenous levels of SSX protein.

  • 基因名称

    SSX1/SSX2/SSX3/SSX4/SSX5/SSX6/SSX7/SSX8/SSX9

  • 蛋白名称

    Protein SSX1/Protein SSX2/Protein SSX3/Protein SSX4/Protein SSX5/Protein SSX6/Protein SSX7/Protein SSX8/Protein SSX9

  • 别名

    SSX1;Protein SSX1;Cancer/testis antigen 5.1;CT5.1;Synovial sarcoma, X breakpoint 1;SSX2;SSX2A;SSX2B;Protein SSX2;Cancer/testis antigen 5.2;CT5.2;Synovial sarcoma, X breakpoint 2;Tumor antigen HOM-MEL-40;SSX3;Protein SSX3;Cancer/testis antigen 5.3;CT5.3;SSX4;SSX4A;SSX4B;Protein SSX4;Cancer/testis antigen 5.4;CT5.4;SSX5;Protein SSX5;SSX6;Putative protein SSX6;SSX7;Protein SSX7;SSX8;Protein SSX8;SSX9;Protein SSX9

  • Organism-1

    Human

  • 基因ID-1

    6756

  • SwissProt-1

    Q16384

  • 背景

    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. This gene, and also the SSX2 and SSX4 family members, have been involved in t(X;18)(p11.2;q11.2) translocations that are characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are likely responsible for transforming activity. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome X. [provided by RefSeq, Jul 2013],

  • 细胞定位

    nucleus,